Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助科研通管家采纳,获得10
刚刚
zhaoyang完成签到,获得积分20
刚刚
爆米花应助科研通管家采纳,获得10
刚刚
NexusExplorer应助科研通管家采纳,获得10
刚刚
刚刚
丘比特应助科研通管家采纳,获得10
刚刚
酷波er应助科研通管家采纳,获得10
刚刚
桐桐应助科研通管家采纳,获得30
1秒前
搜集达人应助科研通管家采纳,获得10
1秒前
1秒前
vivi应助科研通管家采纳,获得10
1秒前
睿0924发布了新的文献求助10
1秒前
Owen应助科研通管家采纳,获得10
1秒前
长刀介错人完成签到,获得积分10
1秒前
赘婿应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
星辰大海应助科研通管家采纳,获得10
1秒前
vivi应助科研通管家采纳,获得10
1秒前
1秒前
JamesPei应助科研通管家采纳,获得10
1秒前
英姑应助科研通管家采纳,获得10
2秒前
在水一方应助科研通管家采纳,获得10
2秒前
2秒前
酷波er应助科研通管家采纳,获得10
2秒前
2秒前
林结衣完成签到,获得积分10
2秒前
义气的翠完成签到,获得积分10
3秒前
鼻毛好胜发布了新的文献求助10
3秒前
Brown发布了新的文献求助10
3秒前
Ds应助马逑生采纳,获得10
4秒前
无极微光应助UP采纳,获得20
4秒前
整齐的飞丹完成签到,获得积分10
5秒前
elysia完成签到,获得积分10
5秒前
顾矜应助快乐再出发采纳,获得10
6秒前
7秒前
7秒前
8秒前
8秒前
绝世的容颜完成签到,获得积分10
9秒前
源味完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
咳嗽・喀痰の診療ガイドライン第2版2025 800
Petrology and Plate Tectonics 800
Electrode Potentials 550
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
The globalisation of real estate: the politics and practice of foreign real estate investment 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7009127
求助须知:如何正确求助?哪些是违规求助? 8683162
关于积分的说明 18406825
捐赠科研通 6493741
什么是DOI,文献DOI怎么找? 3104257
关于科研通互助平台的介绍 2172928
邀请新用户注册赠送积分活动 2080452